Hematology Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Hematology Market report segments the industry into By Product (Hematology Analyzers, Flow Cytometers, and more), By Reagent (Coagulation Reagents, Flow Cytometery Reagents, and more), By Application (Drug Testing, Auto-immune Diseases, and more), By End User (Hospitals, Clinical Testing Institutes, and more), and Geography (North America, Europe, and more).

Global Hematology Market Size

Compare market size and growth of Global Hematology Market with other markets in Healthcare Industry

Global Hematology Market Analysis

The Global Hematology Market size is estimated at USD 4.96 billion in 2025, and is expected to reach USD 6.50 billion by 2030, at a CAGR of 5.56% during the forecast period (2025-2030).

The growth of the hematology market is attributed to the increasing burden of blood disorders and other related disorders, rapid technological advances in hematology, and the emergence of high throughput hematology analyzers. In addition, the increasing efforts to develop cutting-edge hematology platforms are expected to accelerate market uptake during the study period.

The increasing prevalence of blood and related disorders is anticipated to accelerate demand for various hematology products, such as analyzers, flow cytometers, and centrifuges, to detect potential abnormalities in blood. This trend is likely to shape industry uptake during the study period.

For instance, according to the 2024 updated data from the American Cancer Society, leukemia cases have ramped from 59,610 in 2023 to 59,610 in 2024. Similarly, per the same source, the number of myeloma cases has increased from 35,730 in 2023 to 35,780 in 2024. Hence, the high prevalence of blood cancer is estimated to drive the demand for hematology instruments and consumables, which, in turn, is expected to accelerate market expansion during the study period.

Similarly, the increasing burden of hemophilia and clotting conditions are further expected to spur demand for coagulation analyzers to monitor blood clotting properties. For instance, according to the 2024 updated data of the National Bleeding Disorders Foundation, around 12 in 100,000 people are affected with hemophilia in the United States and around 400 children are born with this condition every year. Such a high burden of hemophilia is anticipated to bolster demand for hematological products and consumables, which is expected to accelerate market growth over the coming years.

In addition, the growing adoption of high-throughput and automated hematology analyzers and several benefits associated with automated analyzers are expected to boost market expansion during the study period. Modern hematology analyzers are highly automated, offering increased throughput, reduced turnaround time, and improved accuracy, making them more efficient and cost-effective.

For instance, according to an article published by the Indian Journal of Hematology and Blood Transfusion in August 2023, advanced automated high-throughput analyzers allow the measurement of different hematological parameters in a more objective and precise manner compared to manual methods and have less turnaround time, which makes them more popular among end users. Thus, the growing adoption of high-throughput analyzers and the several benefits are projected to propel market growth forward over the coming years.

Also, prominent players' active participation in the market and ongoing technological advancements and product launches are further projected to spur market growth. For instance, in May 2023, Sysmex Corporation launched its Clinical Flow Cytometry System Flow Cytometer XF-1600 in Japan after its commercial success in Europe and North America. This launch helped the company to strengthen the diagnosis of hematological diseases such as leukemia and malignant lymphoma in Japan.

In addition, in June 2022, Thermo Fisher Scientific Inc. introduced the new EliA RNA Pol III and EliA Rib-P blood tests to diagnose systemic sclerosis and systemic lupus erythematosus (SLE), thus further expanding its comprehensive menu of automated connective tissue disease tests. Thus, such developments undertaken by prominent players are augmenting the market growth.

The factors mentioned above, such as the increasing prevalence of hematological disorders, the rising use of high-throughput systems, and various strategic initiatives carried out by market players, are anticipated to drive market growth in the coming years.

However, the high cost of instruments and the lack of skilled laboratory professionals are expected to hinder market expansion during the study period.

Global Hematology Industry Overview

The hematology market is fragmented in nature. Some key industry players include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Siemens Healthineers, and F. Hoffmann-La Roche Ltd. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, partnerships, and investments in research and development activities, which help them strengthen their market positions globally.

Global Hematology Market Leaders

  1. Thermo Fisher Scientific Inc

  2. Abbott

  3. Danaher

  4. Bio-Rad Laboratories, Inc

  5. Siemens Healthineers AG

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Global Hematology Market News

  • March 2024: Beckman Coulter Life Sciences launched CytoFLEX, a nano flow cytometer for research. The newly launched cytometer has an improved sensitivity to detect and characterize nanoparticles.
  • April 2024: HORIBA Medical planned to launch a new HELO 2.0 high throughput automated hematology platform in the United States after receiving approval from the US Food and Drug Administration. This product is designed to transform operations in high throughput, fully automated hematology space.

Global Hematology Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Blood Disorders and Other Diseases
    • 4.2.2 Rapid Technological Advances in Hematology
    • 4.2.3 Emergence of High Throughput Hematology Analyzers
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments
    • 4.3.2 Low Adoption of Hematology Analyzers in Emerging Economies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD)

  • 5.1 By Product
    • 5.1.1 Hematology Analyzers
    • 5.1.2 Flow Cytometers
    • 5.1.3 Coagulation Analyzers
    • 5.1.4 Slide Stainers
    • 5.1.5 Centrifuges
    • 5.1.6 Hemoglobinometers
    • 5.1.7 Other Products
  • 5.2 By Reagent
    • 5.2.1 Coagulation Reagents
    • 5.2.2 Flow Cytometery Reagents
    • 5.2.3 Immuno-hematology Reagents
    • 5.2.4 Other Reagents
  • 5.3 By Application
    • 5.3.1 Drug Testing
    • 5.3.2 Auto-immune Diseases
    • 5.3.3 Cancer
    • 5.3.4 Diabetes Mellitus
    • 5.3.5 Infectious Diseases
    • 5.3.6 Other Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Clinical Testing Institutes
    • 5.4.3 Patient Self-testing
    • 5.4.4 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott
    • 6.1.2 Agilent Technologies Inc.
    • 6.1.3 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
    • 6.1.4 Bio-Rad Laboratories Inc.
    • 6.1.5 Siemens Healthineers AG
    • 6.1.6 Danaher
    • 6.1.7 Thermo Fisher Scientific Inc.
    • 6.1.8 F. Hoffmann-La Roche Ltd
    • 6.1.9 Everlife CPC Diagnostics
    • 6.1.10 Sysmex
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Hematology Industry Segmentation

As per the scope of the study, hematology is a branch of medicine that deals with blood and blood-related disorders. Hematology tests include various tests on the blood, blood proteins, and blood-producing organs to evaluate a variety of blood conditions, including infection, anemia, inflammation, hemophilia, blood-clotting disorders, leukemia, and the body’s response to chemotherapy treatments.

The hematology market is segmented by product, reagents, application, end user, and geography. Based on product, the market is segmented as hematology analyzers, flow cytometers, coagulation analyzers, slide stainers, centrifuges, hemoglobinometers, and other products. Based on reagents, the market is segmented into coagulation reagents, flow cytometry reagents, immuno-hematology reagents, and other reagents. Based on application, the market is segmented into drug testing, auto-immune diseases, cancer, diabetes mellitus, infectious diseases, and other applications. Based on end user, the market is segmented into hospitals, clinical testing institutes, patient self-testing, and other end users. By geography, the market is segmented into major regions like North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

The report also covers the market sizes and forecasts for the hematology market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).

By Product Hematology Analyzers
Flow Cytometers
Coagulation Analyzers
Slide Stainers
Centrifuges
Hemoglobinometers
Other Products
By Reagent Coagulation Reagents
Flow Cytometery Reagents
Immuno-hematology Reagents
Other Reagents
By Application Drug Testing
Auto-immune Diseases
Cancer
Diabetes Mellitus
Infectious Diseases
Other Applications
By End User Hospitals
Clinical Testing Institutes
Patient Self-testing
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product
Hematology Analyzers
Flow Cytometers
Coagulation Analyzers
Slide Stainers
Centrifuges
Hemoglobinometers
Other Products
By Reagent
Coagulation Reagents
Flow Cytometery Reagents
Immuno-hematology Reagents
Other Reagents
By Application
Drug Testing
Auto-immune Diseases
Cancer
Diabetes Mellitus
Infectious Diseases
Other Applications
By End User
Hospitals
Clinical Testing Institutes
Patient Self-testing
Other End Users
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Global Hematology Market Research Faqs

How big is the Global Hematology Market?

The Global Hematology Market size is expected to reach USD 4.96 billion in 2025 and grow at a CAGR of 5.56% to reach USD 6.50 billion by 2030.

What is the current Global Hematology Market size?

In 2025, the Global Hematology Market size is expected to reach USD 4.96 billion.

Who are the key players in Global Hematology Market?

Thermo Fisher Scientific Inc, Abbott, Danaher, Bio-Rad Laboratories, Inc and Siemens Healthineers AG are the major companies operating in the Global Hematology Market.

Which is the fastest growing region in Global Hematology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Hematology Market?

In 2025, the North America accounts for the largest market share in Global Hematology Market.

What years does this Global Hematology Market cover, and what was the market size in 2024?

In 2024, the Global Hematology Market size was estimated at USD 4.68 billion. The report covers the Global Hematology Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Hematology Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Hematology Industry Report

The analysis report on the Hematology Market provides a comprehensive market research overview, detailing the market share and market size of various segments. The global market for hematology is segmented by product types, reagents, applications, end users, and geographical regions. The report includes a detailed industry report and industry research, offering insights into market trends and market analysis.

The market report highlights the growth rate and market forecast, providing an industry outlook up to the forecast period. The industry information includes market growth, market leaders, and market outlook, giving a thorough understanding of the market dynamics. The industry analysis also covers market data, market predictions, and market review, ensuring a complete market overview.

The report example and report pdf are available for download, providing detailed industry statistics and industry trends. The market segmentation includes various applications and end users, while the market value is analyzed across different regions. The research companies involved in this market study provide valuable insights into industry sales and industry size.

Overall, the Hematology Market report offers a detailed and insightful market analysis, covering all aspects of the industry, including market forecast, market growth, and market segmentation. The report is an essential resource for understanding the market value and industry trends in the global hematology market.

Global Hematology Market Report Snapshots